- Recommendation ID
- NG161/2
- Question
Duration of risk of systemic anticancer treatment in people with cancer and COVID-19: Are people who have had SACT recently (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of poor outcomes from COVID-19 compared with those who had SACT less recently?
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- COVID-19 rapid guideline: delivery of systemic anticancer treatments
- Number
- NG161
- Date issued
- March 2020
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/09/2021 |